Abstract

Medical science needs high-quality nursery and technical assistance. To improve the quality and diversity of nursing services and technical support various factors like medical science advances, economic consideration, and clinical requirements play a major role. This article addresses the need for medical promotion and effective projects on a number of aspects of nursery science—including college education, medical knowledge advances, clinical requirements, and technical innovation.

Keywords:

Healthcare; nursing; medical service; modern technology; education, personalized medicine, obesity; psycho-analysis;

Introduction

Historic overview

Today, medical science is progressing by leaps and bounds. Healthcare continues to improve with and without huge financial supports [5-13]. The treatment processes are not confined to operationroom (surgery) and drug utility (chemical, herbal or bio agents) [1]. On one side, Better bedside facilities demand a new generation of medical (surgery, drug, nutrition and instruments) and nursery services (physical or spiritual assistance) [1-4]. Whereas on the other hand, both chronic or acute patients in any general hospital could be better served by investing on both doctors, and nursing programs [14-17]. The rapid progress of nursery service is quintessential to improve health-care and achieve patient recognition.

Current progress

As nursery science continues to progress fast, the medical significance of the quality improvements of medical healthcare and nursing activity becomes very obvious [1-12]. Medical care and nursing advances help in controlling the disease and aiding in patient’s recovery in the clinic. Medical knowledge advances will certainly aid in improving bedside conditions.

Methods

Following methodologies would be useful means to improve the nursery practices in all the hospitals globally:

Knowledge Spread

There is no nursery knowledge that can be applied to every medical discipline. Hence, it suggests that knowledge transfer should target as many different biomedical disciplines as possible [16]. Table 1 and Table 2 show a glimpse of the major skills that nurses in every discipline should be familiar with [13-18]. (Table 1 & Table 2).

System establishments

It is obvious that capability promotion of nurses can greatly improve patient’s health care. Though hospitals provide nursery services according to their capability and interests, nursery system developments should not be neglected in hospitals. Excellent health care services including provision of nurses should be made to every patient. Furthermore, with an increase in number of hospitals, individualized nursing systems should also be established in the upcoming decades.

Pharmacological knowledge

Currently, the era is of personalized medicines [18-24]. There has been a dramatic increase in every aspect of pharmacology such as drug and technical developments, clinical pharmacology and toxicology including nursing education. Depending on various physiological parameters and patho-physiological conditions like body mass index (BMI), patient age, height, comorbidity, and other complications which differs from patient to patient, the need of different healthcare services varies. [25-28]. Doctors are often not able to guide and monitor all these different services, especially drug toxicology. Thus, advances in pharmacological knowledge of nurses will help in other aspects too. Moreover, even the cost balance between doctors’ diagnosis/prescription and patients’ nursing activity are future avenues. Furthermore, nurses may also report some treatment mistakes including drug toxicology and therapeutic failures of doctors to higher regulatory levels and network [29].

Patient emotion control

Patients are often anxious, agitated, excited or depressed either because of the agony of disease progress or because the treatment outcomes are different from their expectations. Patients psychiatric condition are often not stable. As mental condition contributes to therapeutic outcomes, considerable spiritual supports which improves mental states can change the course of disease recovery aiding in faster recovery [11]. Hence, in any kind of medical treatment, it should be made a therapeutic routine.

Diversity of Nursery work

Nurses perform many functions in hospitals. (Table 3). Hence, they should be trained in advance for different activities and services. Moreover, they need to have this mindset before they enter into hospitals and healthcare centres.

Future Directions

Joint efforts

Therapeutics in the future will no longer be decision-making by doctors only [30-31]. Many technical and assisting forces like pharmacologists, pathologists, biochemical technologists, nurses, mathematicians and patients family members including patients themselves are entering in the niche once occupied by doctors only, and will take part in different avenues of medical practice. Without the assistance of these experts and family members, clinical doctors will be limited in their actions of providing better health care facilities and it will also be difficult to execute the best therapeutics for every patient. This modern trend which is all- inclusive is unavoidable and eventually will improve globally.

Targets for different disease categories and pharmacology

To summarize, different types of nursing activities play key roles in different clinical practices, be it chronic diseases or acute diseases, which includes but is not limited to viral infections [32-35], mental diseases [36-39], bone disorders [40-43], metabolic diseases [44-49], or cancer metastasis treatments [50-58]. Hence, nurses should be familiar with the knowledge of all these medical disciplines and execute their services meticulously.

Conclusion

Patient’s nursery service plays vital roles in modern hospitals. To promote these kinds of medical and technical work, new nursery systems must be established for quality promotion and disease treatments. Additionally, nursery activities should be emphasized for all medical disciplines and patient treatments. In this regard, every effort will be useful in the treatment and recovery of patients. Advancement of nursery practices will go a long way to improve every facet of health care facility.

Conflict of interest:

The authors have declare no conflict of interest.

References

1. Lu DY, Lu TR (2019) Herbal medicine in new era. Hospice Palliative Medicine International J 3: 125-130.View

2. Lu DY, Chen YZ, Lu DF, Che JY (2019) Patient’s care and nursery in different diseases. Hospice & Palliative Medicine International Journal 3: 28-30. View

3. Lu DY, Chen YZ, Lu DF, Che JY (2019) Patient’s care and nursery in modern medicine. Nursery Practice and Health Care 1: 101.View

4. Lu DY, Chen YZ, Lu DF (2019) Nursery education, capability and service promotion. Open Access J Nursery 2: 1-4.View

5. Iqbal U, Humayyn A, Li YC (2019) Healthcare quality improvement and measurement strategies and its challenges ahead. Int J Quality in Health Care 31: 1.View

6. Iqbal U, Rabrenovic M, Li YC (2019) Healthcare quality challenges in low- and middle-income countries 31: 165.View

7. Lu DY, Che JY, Putta S, Wu HY, Shen Y, et al. (2019) How to improve the quality of pharmacotherapy for bone diseases. EC Orthopeadicis 10: 366-369.View

8. Leebov W, Scott G (1996) Service quality improvement. The customer satisfaction strategy for healthcare. J Healthcare Quality 18: 35.

9. Lu DY, Chen YZ, Lu DF (2019) Nursery service, quality promotion. Hospice & Palliative Medicine International J 3: 97-98.View

10. Lu DY, Chen YZ, Lu DF, Che JY (2019) Nursery service in modern day. Adv Biomedical Engineering Biotechnology 1: 1-2View

11. Lu DY (2019) Bone disease recovery strategies, nursery importance. EC Dental Science 18: 326-327.View

12. Ghaffari M (2019) Building a community of learners: Lessons learned. Nursery Practice and Health Care 1: 104.

13. An Old Disease (2013) A New Insights. Ed, Shamm Ahmad, 2013, Springer Science, US.View

14. Zimmet PZ, Magliano DJ, Herman WH, Shaw JE (2014) Diabetes; a 21st century challenge. Lancet Diabetes Endocrinol 2: 56-64. View

15. Grimaccia F, Kanavos P (2014) Cost, outcome, treatment pathways and challenges for diabetes care in Italy. Global Health 10: 58.View

16. Lu DY (2017) Suicide Risks and Treatments, New Ideas and Future Perspectives. Ed Da-Yong Lu, Nova Science Publishers.View

17. Lu DY (2017) HIV/AIDS Treatments, Fight for a Cure. LAMBERT Academic Publishing. Ed Da-Yong Lu.

18. Lu DY (2014) Personalized cancer chemotherapy, an effective way for enhancing outcomes in clinics.View

19. Lu DY, Chen XL, Ding J (2006) Individualized cancer chemotherapy integrating drug sensitivity tests, pathological profile analysis and computational coordination an effective strategy to improve clinical treatment. Medical Hypotheses 66: 45-51.View

20. Lu DY, Lu TR, Ding J, Xu B, Che JY (2015) Anticancer drug sensitivity testing, a historical review and future perspectives. Current Drug Therapy 10: 44-55.View

21. Lu DY, Lu TR, Xu B, Ding J (2015) Pharmacogenetics of cancer therapy: breakthroughs from beyond? Future Science OA 1: FSO.15: 80.View

22. Lu DY, Lu TR, Che JY, Yarla NS (2018) Individualized cancer therapy, what is the next generation? EC Cancer 2: 286-297View

23. Lu DY, Xu B, Ding J, Lu TR, Yarla NS et al. (2018) Cancer Bioinformatics in Cancer Therapy. Adv Proteomics Bioinformatics 1: 11.View

24. Lu DY, Lu TR, Che JY, Shen Y, Yarla NS et al. (2018) Individualized cancer therapy, future approaches. Current Pharmacogenomics & Personalized Medicine 16: 156-163.View

25. Lu DY, Che JY, Putta S (2018) Obese study, keep up the momentum. Int J Endocrinology Res 1: 1-3.View

26. Lu DY, Che JY, Yarla NS, Putta S, Lin LP (2019) Human obesity, pathological and therapeutic advances. EC Pharmacology & Toxicology 7: 231-238.View

27. Lu DY, Che JY, Shen Y (2018) Clinical treatments of osteoporosis, how to target co-morbidities. EC Orthopaedics. 2018, 9 (11), 781-782.

28. Lu DY, Che JY, Shen ZM, Tong LJ, Lin LP et al. (2019) Osteoporosis treatments for old people. EC Orthopeadicis 10: 278-280.View

29. Dirik HF, Samur M, Intepeler SS, Hewison A (2018) Nurses’ identification and reporting of medication errors. J Clin Nursing 1-8.View

30. Lu DY, Zhu PP, Lu TR, Che JY (2016) The suicidal risks and treatments, seek medications from multi-disciplinary. Cent Nerv Syst Agents Med Chem 16: 231-239.View

31. Lu DY, Zhu PP, Wu HY, Lu Y, Che JY (2017) New modes of suicide/mental disorder diagnostics and therapeutics. Suicide Risks and Treatments, New Ideas and Future Perspectives. Ed Da-Yong Lu, Chapter 5, pp51-62, Nova Science Publishers, New York, US. View

32. Lu DY, Wu HY, Yarla NS, Xu B, Ding J (2018) HAART in HIV/AIDS treatments, future trends. Infectious Disorders-Drug Targets 18: 15-22.View

33. Lu DY, Wu HY, Ding J, Sastry N, Lu TR (2016) HIV vaccine for prevention and cure, a mission possible. Rev Recent Clini Trials 11: 290-296.View

34. Lu DY, Lu TR, Wu HY, Yarla NS, Ding J (2018) HIV/AIDS curable study, new forms of therapeutic trinity. Rec Pat Antiinfect Drug Discov 13: 217-227.View

35. Lu DY, Wu Hy, Yarla NS, Lu TR, Xu B, et al. (2019) Ebola therapeutic study and future trends. Infect Disorder Drug Targets 19: 17-29.View

36. Serafini G, Salano P, Amore M (2015) Suicidal ideation: a comprehensive overview. Suicidal Ideation: Predictors, Prevalence and Prevention. Ed. Bradley Weaver. Nova Science Publishing. US.

37. While D, Bickley H, Roscoe A, Windfuhr K, Rahman S, et al. (2012) Implementation of mental health service recommendations in England and Wales and suicide rates, 1997-2006: a cross-sectional and before-and-after observational study. Lancet 379: 1005-1012.View

38. Lu DY, Lu TR, Lu Y, Cao S (2017) Introduction for suicide study. Journal Metabolic Syndrome 6: 227View

39. Lu DY, Zhu PP, Wu HY, Yarla NS, Xu B, et al. (2018) Human suicide risk and treatment study. Cent Nerv Syst Agents Med Chem 18: 206-212.View

40. Melton J (1993) “Hip fracture; a worldwide problem today and tomorrow” Bone 14: S1-8.

41. Silva DMW (2018) Diagnosis of osteoporosis; bone mineral density, risk factors, or both”. EC Orthopaedics 9: 500-502.View

42. Lu DY, Che JY, Shen Y (2018) Osteoporosis in old women, therapeutic selection. EC Orthopaedics 9: 386.View

43. Lu DY, Che JY, Shen Y (2018) Clinical treatments of osteoporosis, how to target co-morbidities. EC Orthopaedics 9: 781-782.

44. Putta S, Peluso I, Yarla NS, Kilari EK, Bishayee A, et al. (2017) Diabetes mellitus and male aging, pharmacotherapeutics and clinical implications. Current Pharmaceutical Design 23: 6321- 6346.View

45. Lu DY, Che JY, Yarla NS, Zhu H, Lu TR, et al. (2018) Type 2 diabetes study, introduction and perspective. The Open Diabetes J 8: 13-21.View

46. Lu DY, Che JY, Yarla NS, Wu HY, Lu TR, et al. (2018) Ding J, Lu Y, Zhu H. Type 2 diabetes treatment and drug development study. The Open Diabetes J 8: 22-33.View

47. Lu DY, Che JY, Lu Y, Yarla NS, Xu B, et al. (2018) An overview of obesity. Metabolomics 8: 200.View

48. Lu DY, Che JY, Wu HY, Yarla NS, Xu B, et al. (2018) Obesity, risks and managements. Metabolomics 8: e156.View

49. Lu DY, Che JY, Lu TR, Lu Y, Huang YK, et al. (2018) Pathology and treatments of obesity. Trends in Medicine 8: 157.View

50. Lu DY, Lu TR, Wu HY, Cao S (2013) Cancer Metastasis treatments. Current Drug Therapy 8: 24-29.View

51. Nieto MA, Huang RY, Jackson RA, Thiery JP. EMT: (2016) Cell 166: 21-45.View

52. Lu DY, Lu TR, Xu B, Qi RX, Sastry NY, et al. (2016) Cancer metastasis, a clinical dilemma for therapeutics. Current Drug Therapy 11: 163-169.View

53. Lu DY, Xu B, Ding J (2004) Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo. BMC Pharmacology 4: 32.View

54. Lu DY, Huang M, Hu CX, Yang WY, Hu CX et al. (2005) Antiproliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines. BMC Pharmacology 5: 11.View

55. Lu DY, Chen XL, Ding J (2007) Treatment of solid tumors and metastases by fibrinogen-targeted anticancer drug therapy. Medical Hypotheses 68: 188-193.View

56. Lu DY, Lu TR (2010) Antimetastatic activities and mechanisms of bisdioxopiperazine compounds. Anti-Cancer Agent Medicinal Chemistry 10: 564-570.View

57. Lambert AW, Pattabiraman DR, Weinberg RA (2017) Emerging biological principles of metastasis Cell 168: 670-691.View

58. Putta S, Yarla NS, Peluso I, Tiwari DK, Reddy GV et al.(2017) Anthocyanins: Possible role as multitarget therapeutic agents for prevention and therapy of chronic diseases. Current Pharmaceutical Design. 23: 4475-4483.